These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3278606)

  • 1. Blunted kaliuresis after an acute oral potassium load in diabetes mellitus.
    Smoller S; Rashid K; Perez GO; Oster JR; Vaamonde CA
    Am J Med Sci; 1988 Feb; 295(2):114-21. PubMed ID: 3278606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blunted kaliuresis after an acute potassium load in patients with chronic renal failure.
    Perez GO; Pelleya R; Oster JR; Kem DC; Vaamonde CA
    Kidney Int; 1983 Nov; 24(5):656-62. PubMed ID: 6663988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent hyperkalemia in a patient with diabetes mellitus: a reversible defect in kaliuresis during bicarbonaturia.
    Kaiser UB; Ethier JH; Kamel KS; Halperin ML
    Clin Invest Med; 1992 Apr; 15(2):187-93. PubMed ID: 1591899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperkalemia in a diabetic due to renal tubular unresponsiveness to aldosterone.
    Bannister KM; Barratt LJ
    Aust N Z J Med; 1982 Feb; 12(1):63-6. PubMed ID: 7044358
    [No Abstract]   [Full Text] [Related]  

  • 5. The renin-angiotensin-aldosterone system in diabetic patients with hyperkalemia.
    Sunderlin FS; Anderson GH; Streeten DH; Blumenthal SA
    Diabetes; 1981 Apr; 30(4):335-40. PubMed ID: 7009278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amiloride on oral glucose loading, serum potassium, renin, and aldosterone in diet-controlled diabetes.
    Lowenthal DT; Gould A; Shirk J; Mazzella J; Affrime MB; Walker F; Onesti G
    Clin Pharmacol Ther; 1980 May; 27(5):671-6. PubMed ID: 6989547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients.
    Bantle JP; Nath KA; Sutherland DE; Najarian JS; Ferris TF
    Arch Intern Med; 1985 Mar; 145(3):505-8. PubMed ID: 3883934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone responsiveness in patients with diabetes mellitus.
    Christlieb AR; Kaldany A; D'Elia JA; Williams GH
    Diabetes; 1978 Jul; 27(7):732-7. PubMed ID: 658619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired partial corticosterone methyl oxidase type II defect in diabetes mellitus. Case of hyperreninemic hypoaldosteronism.
    Braithwaite SS; Barbato AL; Emanuele MA
    Diabetes Care; 1990 Jul; 13(7):790-2. PubMed ID: 2167193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired sodium excretion in response to volume expansion induced by water immersion in insulin-dependent diabetes mellitus.
    O'Hare JP; Roland JM; Walters G; Corrall RJ
    Clin Sci (Lond); 1986 Oct; 71(4):403-9. PubMed ID: 3530611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyporeninemia and hypoaldosteronism in diabetes mellitus.
    Perez GO; Lespier L; Jacobi J; Oster JR; Katz FH; Vaamonde CA; Fishman LM
    Arch Intern Med; 1977 Jul; 137(7):852-5. PubMed ID: 879919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin aldosterone system and potassium levels in chronic lead intoxication.
    Gonzalez JJ; Werk EE; Thrasher K; Behar R; Loadholt CB
    South Med J; 1979 Apr; 72(4):433-6, 440. PubMed ID: 107594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone responsiveness to an acute potassium load in diabetes mellitus and chronic renal insufficiency.
    Perez GO; Oster JR
    Horm Res; 1987; 27(1):30-5. PubMed ID: 3305279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.
    Blumberg A; Weidmann P; Shaw S; Gnädinger M
    Am J Med; 1988 Oct; 85(4):507-12. PubMed ID: 3052050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of hyperkalemia in systemic lupus erythematosus.
    Lee FO; Quismorio FP; Troum OM; Anderson PW; Do YS; Hsueh WA
    Arch Intern Med; 1988 Feb; 148(2):397-401. PubMed ID: 3277563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of glucose-induced hyperkalemia by sodium restriction in "normaldosteronemic" diabetes mellitus.
    Radó JP
    Endokrinologie; 1981 Dec; 78(2-3):244-52. PubMed ID: 7037374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperkalemia after renal transplantation. Occurrence in a patient with insulin-dependent diabetes.
    Rosenbaum R; Hoffsten PE; Cryer P; Klahr S
    Arch Intern Med; 1978 Aug; 138(8):1270-2. PubMed ID: 354542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arterial hypertension with hyperkalemia, tubular acidosis and normal renal function: Gordon syndrome and/or pseudohypoaldosteronism type II?].
    Ader JL; Waeber B; Suc JM; Brunner HR; Tran-Van T; Durand D; Praddaude F
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():193-7. PubMed ID: 2973296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical glucose-induced hyperkalemia. Combined aldosterone-insulin deficiency.
    Goldfarb S; Strunk B; Singer I; Goldberg M
    Am J Med; 1975 Nov; 59(5):744-50. PubMed ID: 1200041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.